Showing results (61-70 of 142) with videos related to
Sort By:
Pageof 15
The American Journal of the Medical Sciences|June 18, 1999
Prevention of renal osteodystrophy in predialysis patientsC P Sanchez, W G Goodman, I B SaluskyAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1988
Renal osteodystrophy: some new questions on an old disorderD B Lee, W G Goodman, J W CoburnInsect Biochemistry and Molecular Biology|December 3, 2002
Sequence, structure and expression of the hemolymph juvenile hormone binding protein gene in the tobacco hornworm, Manduca sextaA P Orth, S C Doll, W G GoodmanPediatric Nephrology (Berlin, Germany)|July 27, 2000
Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidismI B Salusky, W G Goodman, B D KuizonCurrent Opinion in Nephrology and Hypertension|July 1, 1993
Recent advances in the management of renal osteodystrophy in childrenI B Salusky, J A Ramirez, W G GoodmanKidney International|January 5, 2000
Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidismM Wada, N Nagano, Y Furuya, et al.Kidney International|February 14, 1998
NPS R-568 halts or reverses osteitis fibrosa in uremic ratsM Wada, H Ishii, Y Furuya, et al.Bone|March 25, 2000
Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalaciaH Ishii, M Wada, Y Furuya, et al.Molecular Pharmacology|June 17, 1998
Allosteric activation of the Ca2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568L G Hammerland, J E Garrett, B C Hung, et al.The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca(2+) receptor in ratsJ Fox, S H Lowe, R L Conklin, et al.Pageof 15